A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2

American Journal of Obstetrics and Gynecology

Volumn 212, Issue 4, 2015, Pages 465.e1-465.e7

  Hillemanns, Peter ^a   Garcia, Francisco ^c   Petry, Karl Ulrich ^b   Dvorak, Vladimír ^d   Sadovsky, Oliver ^e   Iversen, Ole Erik ^f   Einstein, Mark H ^g  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Wolfsburg City Hospital   (Germany)

^c UNIVERSITY OF ARIZONA   (United States)

^d Center of Outpatient Gynecology Clinic and Primary Care   (Czech Republic)

^e Private Veterinary Practice   (Slovakia)

^f UNIVERSITY OF BERGEN   (Norway)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cervical intraepithelial neoplasia; hexaminolevulinate; human papillomavirus; photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; PLACEBO; 5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ADULT; ARTICLE; BLOOD BIOCHEMISTRY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GYNECOLOGIST; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAPANICOLAOU TEST; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPOTTING; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VAGINA DISCHARGE; VAGINAL DISCOMFORT; VITAL SIGN; ADOLESCENT; ANALOGS AND DERIVATIVES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; INTENTION TO TREAT ANALYSIS; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AMINOLEVULINIC ACID; CERVICAL INTRAEPITHELIAL NEOPLASIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84930403692     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.10.1107     Document Type: Article

References (24)

1. M. Plummer, M. Schiffman, P.E. Castle, D. Maucort-Boulch, C.M. Wheeler for the ALTS group A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion J Infect Dis 195 2007 1582 1589
2. S. Albrechtsen, S. Rasmussen, S. Thoresen, L.M. Irgens, and O.E. Iversen Pregnancy outcome in women before and after cervical conization: population-based cohort study BMJ 18 2008 337
3. B. Noehr, A. Jensen, and K. Frederiksen Loop electrosurgical excision of the cervix and subsequent risk of spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period Am J Obstet Gynecol 201 2009 33.e1 33.e6
4. A. Castanon, P. Brocklehurst, and H. Evans Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study BMJ 345 2012 e5174
5. M. Arbyn, M. Kyrgiou, and C. Simoens Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis BMJ 337 2008 a1284
6. L.S. Massad, M.H. Einstein, and W.K. Huh 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors Obstet Gynecol 121 2013 829 846
7. J.A. O'Shaughnessy, G.J. Kelloff, and G.B. Gordon Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development Clin Cancer Res 8 2002 314 346
8. K. Kawana, A. Katsuyuki, S. Kojima, S. Kozuma, and T. Fujii Therapeutic human papillomavirus vaccines: a novel approach Open Virol J 5 Suppl 2012 S264 S269
9. A. Francois, A. Salvadori, A. Bressenot, L. Bezdetnaya, F. Guillemin, and M.A. D'Hallewin How to avoid local side effects of bladder photodynamic therapy: impact of the fluence rate J Urol 190 2013 731 736
10. Z. Luksiene, I. Eggen, J. Moan, J.M. Nesland, and Q. Peng Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells Cancer Lett 169 2001 33 39
11. I.E. Furre, S. Shahzidi, and Z. Luksiene Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells Cancer Res 65 2005 11051 11060
12. E. Kabingu, A.R. Oseroff, G.E. Wilding, and S.O. Gollnick Enhanced systemic immune reactivity to a basal cell carcinoma associated antigen following photodynamic therapy Clin Cancer Res 15 2009 4460 4466
13. S.O. Gollnick, and C.M. Brackett Enhancement of anti-tumor immunity by photodynamic therapy Immunol Res 46 2010 216 226
14. P. Soergel, G.F. Dahl, M. Onsrud, and P. Hillemanns Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate-a double-blind, dose-finding study Lasers Surg Med 44 2012 468 474
15. Einstein M, Sordal T, Lunde T. Safety of hexaminolevulinate photodynamic therapy-a non-extirpative treatment for cervical neoplasia (CIN). Paper presented at: American Society for Colposcopy and Cervical Pathology (ASCCP): 2012; San Francisco, CA.
16. N. Etminan, C. Peters, and E. Bünemann Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro Br J Cancer 105 2011 961 969
17. A.G. Östör Natural history of cervical intraepithelial neoplasia: a critical review Int J Gynecol Pathol 12 1993 186 192
18. P. Soergel, X. Wang, H. Stepp, H. Hertel, and P. Hillemanns Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate Lasers Surg Med 40 2008 611 615
19. Soergel P, Dannecker C, Petry KU, Collinet P, Runnebaum I, Hillemanns P. Hexaminolevulinate photodynamic therapy in patients with CIN1. Paper presented at: 27th International Papillomavirus Conference; Sept. 17-22, 2011; Berlin, Germany.
20. P. Soergel, R. Loehr-Schulz, M. Hillemanns, S. Landwehr, L. Makowski, and P. Hillemanns Effects of photodynamic therapy using topical applied hexylaminolevulinate and methylaminolevulinate upon the integrity of cervical epithelium Lasers Surg Med 42 2010 624 630
21. P. Hillemanns, X. Wang, and H. Hertel Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia Am J Obstet Gynecol 198 2008 300.e1 300.e7
22. S. Andrejevic-Blant, A. Major, and F. Lüdicke Time-dependent hexaminolevulinate-induced protoporphyrin IX distribution after topical application in patients with cervical intraepithelial neoplasia: a fluorescence microscopy study Lasers Surg Med 35 2004 276 283
23. R.E. Behrman, A.S. Butler Committee on Understanding Premature Birth and Assuring Healthy Outcomes. Preterm birth: causes, consequences and prevention 2007 National Academies Press Washington, DC
24. S.K. Kjaer, K. Frederiksen, C. Munk, and T. Iftner Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence J Natl Cancer Inst 102 2010 1478 1488